Ameritas Investment Partners’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44K | Hold |
12,730
| – | – | ﹤0.01% | 2266 |
|
|
2025
Q1 | $33.4K | Hold |
12,730
| – | – | ﹤0.01% | 2326 |
|
|
2024
Q4 | $52.4K | Buy |
12,730
+3,760
| +42% | +$15.5K | ﹤0.01% | 2149 |
|
|
2024
Q3 | $63.5K | Hold |
8,970
| – | – | ﹤0.01% | 2056 |
|
|
2024
Q2 | $58.5K | Hold |
8,970
| – | – | ﹤0.01% | 2057 |
|
|
2024
Q1 | $74.5K | Hold |
8,970
| – | – | ﹤0.01% | 1915 |
|
|
2023
Q4 | $98.8K | Hold |
8,970
| – | – | ﹤0.01% | 1741 |
|
|
2023
Q3 | $75.4K | Buy |
8,970
+2,159
| +32% | +$18.2K | ﹤0.01% | 1847 |
|
|
2023
Q2 | $85.5K | Hold |
6,811
| – | – | ﹤0.01% | 1701 |
|
|
2023
Q1 | $112K | Hold |
6,811
| – | – | ﹤0.01% | 1460 |
|
|
2022
Q4 | $142K | Buy |
6,811
+1,013
| +17% | +$21.1K | 0.01% | 1357 |
|
|
2022
Q3 | $129K | Hold |
5,798
| – | – | 0.01% | 1317 |
|
|
2022
Q2 | $97K | Buy |
5,798
+390
| +7% | +$6.53K | ﹤0.01% | 1534 |
|
|
2022
Q1 | $162K | Hold |
5,408
| – | – | 0.01% | 1317 |
|
|
2021
Q4 | $166K | Buy |
5,408
+818
| +18% | +$25.1K | 0.01% | 1346 |
|
|
2021
Q3 | $145K | Hold |
4,590
| – | – | 0.01% | 1454 |
|
|
2021
Q2 | $168K | Buy |
4,590
+860
| +23% | +$31.5K | 0.01% | 1379 |
|
|
2021
Q1 | $129K | Buy |
3,730
+987
| +36% | +$34.1K | ﹤0.01% | 1503 |
|
|
2020
Q4 | $114K | Hold |
2,743
| – | – | 0.01% | 1506 |
|
|
2020
Q3 | $117K | Buy |
+2,743
| New | +$117K | 0.01% | 1340 |
|